TUESDAY, July 8, 2025 (HealthDay News) — For tumor-infiltrating lymphocyte (TIL) quantification in melanoma, an artificial intelligence (AI) algorithm demonstrates superior reproducibility and prognostic associations compared with traditional methods, according to a study published online July 3 in JAMA Network Open. Thazin N. Aung, Ph.D., from the Yale University School of Medicine in New Haven, […]
The post AI Better for Tumor-Infiltrating Lymphocyte Quantification in Melanoma Than Traditional Methods first appeared on Physician’s Weekly.
